NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company ("Graphic Packaging" or the "Company") (NYSE:GPK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Graphic Packaging and certain of […]

NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. ("Aerovironment" or the "Company") (NASDAQ:AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aerovironment and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ardent and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Galectin Therapeutics Inc. ("Galectin" or the "Company") (NASDAQ:GALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galectin and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Duluth Holdings Inc. ("Duluth" or the "Company") (NASDAQ:DLTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Duluth and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ:INSM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Insmed and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ:TLX) securities. If you suffered a loss on your Telix Pharmaceuticals Ltd. investment and would like to explore

NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ:XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xoma and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Klarna Group PLC ("Klarna" or the "Company") (NYSE:KLAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE:STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub’s September 2025 initial public offering (the "IPO"), of the important January